SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nevro Corp. (NVRO) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+419.2%).
- 分析师共识目标价 $30.32 (+419.2% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 45/100 其中 1/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — NVRO
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.53
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.06
每股账面价值$0.00
每股营收$11.01
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$30.32 (+419.2%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2015 |
$-2.54 |
$69.61M |
$-67.43M |
-96.9% |
| 2016 |
$-1.12 |
$228.5M |
$-31.78M |
-13.9% |
| 2017 |
$-1.25 |
$326.67M |
$-36.66M |
-11.2% |
| 2018 |
$-1.64 |
$387.29M |
$-49.21M |
-12.7% |
| 2019 |
$-3.37 |
$390.26M |
$-103.69M |
-26.6% |
| 2020 |
$-2.47 |
$362.05M |
$-83.07M |
-22.9% |
| 2021 |
$-3.77 |
$386.91M |
$-131.36M |
-34% |
| 2022 |
$0.08 |
$406.37M |
$3M |
0.7% |
| 2023 |
$-2.56 |
$425.17M |
$-92.21M |
-21.7% |
| 2024 |
$-3.06 |
$408.52M |
$-113.44M |
-27.8% |
